Potential Breakthrough: PXS-5505 Shows Promise Against Pancreatic Cancer

Garvan Institute and Pharmaxis Collaboration for PXS-5505 – Researchers at the Garvan Institute of Medical Research, in collaboration with Australian pharmaceutical company Pharmaxis, have made a significant discovery regarding an experimental treatment for bone marrow cancer. The drug, named PXS-5505, shows promise in treating pancreatic…

Evolving Care for Preterm Infants with Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia (BPD) remains a significant concern for preterm infants born below 32 weeks gestation. This condition poses long-term respiratory and neurodevelopmental challenges, affecting these infants into adulthood. With a higher risk of mortality, cognitive and motor delays, respiratory infections, and abnormal lung function, infants…

Expert Tips: Effective Pre and Post-Workout Skincare Tips

Maintaining healthy skin is crucial, especially for those leading active lifestyles and engaging in regular workouts. An effective skincare routine before and after exercising is vital to preserve skin health and prevent issues such as breakouts. Here, we provide expert advice on what to include…

Potential Breakthrough in Neurodegenerative Diseases Treatment

In a significant scientific breakthrough on Neurodegenerative Diseases Treatment, researchers at the Weizmann Institute of Science have unveiled a protein’s pivotal role in regenerating adult neurons within the peripheral nervous system. Unlike the central nervous system, which comprises the brain and spinal cord and has…

FDA Delays Decision on Sarepta Therapeutics Gene Therapy

Sarepta Therapeutics, a leading biopharmaceutical company, has provided an important update on the potential approval of its groundbreaking gene therapy for Duchenne muscular dystrophy (DMD). The U.S. Food and Drug Administration (FDA) has made the decision to delay its verdict on accelerated approval for the…

Wegovy Obesity Drug Reduces Heart Disease Risk: Study

A recent study conducted in the United States suggests that Novo Nordisk’s obesity drug, semaglutide (sold as Wegovy), not only aids in weight loss but also reduces the risk of heart disease. The study’s findings, presented at the European Congress on Obesity in Dublin, indicate…

Federal Support Urged for Historically Black Medical Schools

Historically Black medical schools are urging the federal government to increase funding and create more training slots to address the shortage of Black doctors. Dr. Hugh Mighty of Howard University emphasized the critical role of HBCU medical schools in training Black doctors at a hearing…

1 2 3 33